AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2023
Aug 17, 2023
31676_dirs_2023-08-16_c591eb43-4f91-4a7f-ba93-a2ca0b4f28be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2023-08-16
Reporting Person: MERIDIAN VENTURE PARTNERS II LP (10% Owner)
Reporting Person: Meridian Venture Partners II GP, L.P. (10% Owner)
Reporting Person: Meridian Venture Partners II, Co. (10% Owner)
Reporting Person: Brown Robert E. JR (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-16 | Common Stock | S | 200000 | $58.50 | Disposed | 1819259 | Direct |
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3